Benefits of Molecular Imaging and More MSK in the News

Posted on by
  • MSK radiologist, Dr. Nancy Lee and Director of MRI, Dr. Oguz Akin, were featured in an April 27 Washington Post article that explained how molecular imaging is a powerful new tool that helps make both the diagnosis and treatment of cancer more targeted.
  • In an April 26 WSJ article, MSK President and CEO Dr. Craig Thompson, explained how despite cancer not yet having been “cured”, recent advances in cancer research and our ever-expanding knowledge of cancer is something to be excited and hopeful about.
  • MSK’s Computational Biology Program Chair, Dr. Chris Sander, was featured in an April 23 article summarizing the keynote address he gave in Boston at the Bio-IT World Conference & Expo. Highlighted was the work he does predicting combinations of targeted therapies to avoid the development of a cancer’s resistance to a single drug. Also mentioned was the cBioPortal visualization & analysis tool developed by his team.

NEW! JAMA Oncology

Posted on by

The long-awaited JAMA Oncology is now available through the MSK Library!

JAMA Oncology is a peer-reviewed journal dedicated to all aspects of medical, radiation, and surgical oncology and its subspecialties. The journal is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer. Authors interested in publishing with this journal — which offers prompt review and decisions and rapid publication — can find more information here.

This resource may be accessed through our Journal A-Z Listing or by searching MSK Search.

Possible New Biomarker, New Pediatric Thyroid Guidelines, Risks for BRAC1/2 and More…

Posted on by

Here are a few highlights of cancer research news that have recently caught my attention:

  • A recent study published in JAMA looked at the mutation-specific cancer risks for carriers of BRAC1 and BRAC2. Study conducted by researchers at Bassa Center for BRCA, the Abramson Center and the Perelman School of Medicine at U Penn evaluated 19,581 carriers of BRCA1 mutations and 11,900 carriers of BRCA2 mutations. They concluded that cancer risks varied by type and location of these mutations.
  • The New York Daily News recently published a piece authored by Dr. Harold Varmus, former director of the National Cancer Institute, where he talks about the progress in cancer research and what lies ahead.
  • According to a study by the American College of Surgeons, socioeconomic factors affect chances of death post lung resection. Study looked at 215, 645 patients.

Continue reading →